I30

N'-[(1E)-1-(1H-benzimidazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide

Created:	2011-07-26
Last modified:	2011-07-26

Find Related PDB Entry
1 entries where I30 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	0
Bond Count	38
Aromatic Bond Count	16

2D diagram of I30

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N'-[(1E)-1-(1H-benzimidazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide
Systematic Name (OpenEye OEToolkits)	N-[(E)-1-(1H-benzimidazol-2-yl)ethylideneamino]-5-bromanyl-2-oxidanyl-benzamide
Formula	C₁₆ H₁₃ Br N₄ O₂
Molecular Weight	373.204
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Brc1cc(c(O)cc1)C(=O)N\N=C(\c3nc2ccccc2n3)C
SMILES	CACTVS	3.370	CC(=NNC(=O)c1cc(Br)ccc1O)c2[nH]c3ccccc3n2
SMILES	OpenEye OEToolkits	1.7.2	CC(=NNC(=O)c1cc(ccc1O)Br)c2[nH]c3ccccc3n2
Canonical SMILES	CACTVS	3.370	C\C(=N/NC(=O)c1cc(Br)ccc1O)c2[nH]c3ccccc3n2
Canonical SMILES	OpenEye OEToolkits	1.7.2	C/C(=N\NC(=O)c1cc(ccc1O)Br)/c2[nH]c3ccccc3n2
InChI	InChI	1.03	InChI=1S/C16H13BrN4O2/c1-9(15-18-12-4-2-3-5-13(12)19-15)20-21-16(23)11-8-10(17)6-7-14(11)22/h2-8,22H,1H3,(H,18,19)(H,21,23)/b20-9+
InChIKey	InChI	1.03	QYPYMNJXDLGLRD-AWQFTUOYSA-N

Related Resource References

Resource Name	Reference
PubChem	135642239
ChEMBL	CHEMBL2206164

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.